In a study examining the potential consequences of ATR or Chk1 mutations in cells with mismatch repair deficiency, Jardim et al. [93] produced HCT116 colon cancer cells in which ATR or Chk1 levels were stably knocked down to 50% of wild type levels. The gene discussed is ATR; the disease is malignant colon neoplasm.